反応式
[F:1][C:2]1[CH:3]=[C:4]([C:8]2[NH:9][CH:10]=[CH:11][N:12]=2)[CH:5]=[CH:6][CH:7]=1.Cl[CH2:14][C:15]1[N:16]=[C:17]2[CH:22]=[CH:21][C:20]([Cl:23])=[CH:19][N:18]2[C:24]=1[CH2:25][CH2:26][CH3:27].CO.C(Cl)Cl>CC(N(C)C)=O.CCOC(C)=O>[Cl:23][C:20]1[CH:21]=[CH:22][C:17]2[N:18]([C:24]([CH2:25][CH2:26][CH3:27])=[C:15]([CH2:14][N:12]3[CH:11]=[CH:10][N:9]=[C:8]3[C:4]3[CH:5]=[CH:6][CH:7]=[C:2]([F:1])[CH:3]=3)[N:16]=2)[CH:19]=1参加物
反応物 3
生成物 1
試薬・触媒・溶媒 2
反応条件
- 温度
- 60 °C
実験手順
Kt-BuO (0.69 mL of 1 M in THF, 0.69 mmol) is added to a solution of 3-fluoro-(1H-imidazol-2-yl)benzene (88 mg, 0.58 mmol) in anhydrous DMA (1 mL). After 15 minutes, 2-chloromethyl-6-chloro-3-(1-propyl)-imidazolo[1,2-a]pyridine (140 mg, 0.58 mmol) is added and the reaction mixture is stirred and heated at 60° C. for 15 minutes. The reaction mixture is diluted with EtOAc (10 mL), washed with water (3 mL), brine (3 mL), dried over Na2SO4, filtered and evaporated at reduced pressure to obtain a yellow solid. Sequential chromatography on silica gel eluting with EtOAc and then 5%MeOH/CH2Cl2 provides 6-chloro-2-{[2-(3-fluoropheny)-1H-imidazol-1-yl]methyl}-3-propylimidazo[1,2-a]pyridine as a cream-colored yellow solid. TLC (10% MeOH/CH2Cl2) Rf=0.35.
後処理
- washwashed with water (3 mL), brine (3 mL)
- dry with materialdried over Na2SO4
- filtrationfiltered
- customevaporated at reduced pressure
- customto obtain a yellow solid
出典と根拠
- ORDレコード
- ord-8d638e36cfbd4aaab052ecb27541dd34
- 出典データセット
- uspto-grants-2005_08
- 特許番号
- US06936617B2
関連ノート
読み込み中…